{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:27:35Z","timestamp":1791282455303,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T00:00:00Z","timestamp":1305072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11940-011-0133-x","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T23:44:46Z","timestamp":1304984686000},"page":"346-354","source":"Crossref","is-referenced-by-count":47,"title":["Treatment of Epilepsy to Optimize Bone Health"],"prefix":"10.1007","volume":"13","author":[{"given":"Alison M.","family":"Pack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"issue":"2","key":"133_CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.seizure.2007.11.020","volume":"17","author":"A Pack","year":"2008","unstructured":"Pack A. Bone health in people with epilepsy: Is it impaired and what are the risk factors? Seizure. 2008;17(2):18.","journal-title":"Seizure"},{"issue":"2","key":"133_CR2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0013-9580.2005.23804.x","volume":"46","author":"PC Souverein","year":"2005","unstructured":"Souverein PC, Webb DJ, Petri H, et al. Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia. 2005;46(2):304\u201310.","journal-title":"Epilepsia"},{"issue":"2","key":"133_CR3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1528-1167.2009.02254.x","volume":"51","author":"SJ Petty","year":"2010","unstructured":"Petty SJ, Hill KD, Haber NE, et al. Balance impairment in chronic antiepileptic drug users: a twin and sibling study. Epilepsia 2010, 51(2):280\u20138.","journal-title":"Epilepsia"},{"issue":"5","key":"133_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","volume":"112","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P. Epilepsy, osteoporosis and fracture risk\u2014a meta-analysis. Acta Neurol Scand. 2005;112(5):277\u201386.","journal-title":"Acta Neurol Scand"},{"key":"133_CR5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0074-7742(08)00018-4","volume":"83","author":"AM Pack","year":"2008","unstructured":"Pack AM, Walczak TS. Bone health in women with epilepsy: clinical features and potential mechanisms. Int Rev Neurobiol. 2008;83:305\u201328.","journal-title":"Int Rev Neurobiol"},{"issue":"7","key":"133_CR6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1528-1157.2002.15801.x","volume":"43","author":"HB Persson","year":"2002","unstructured":"Persson HB, Alberts KA, Farahmand BY, Tomson T. Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia. 2002;43(7):768\u201372.","journal-title":"Epilepsia"},{"issue":"9","key":"133_CR7","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1212\/01.wnl.0000210503.89488.88","volume":"66","author":"PC Souverein","year":"2006","unstructured":"Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts AC. Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology. 2006;66(9):1318\u201324.","journal-title":"Neurology"},{"issue":"12","key":"133_CR8","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/j.1528-1167.2008.01640.x","volume":"49","author":"I Tsiropoulos","year":"2008","unstructured":"Tsiropoulos I, Andersen M, Nymark T, et al. Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study. Epilepsia. 2008;49(12):2092\u20139.","journal-title":"Epilepsia"},{"issue":"11","key":"133_CR9","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.0013-9580.2004.18804.x","volume":"45","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia. 2004;45(11):1330\u20137.","journal-title":"Epilepsia"},{"issue":"5","key":"133_CR10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.59.5.781","volume":"59","author":"DL Andress","year":"2002","unstructured":"Andress DL, Ozuna J, Tirschwell D, et al. Antiepileptic drug\u2013induced bone loss in young male patients who have seizures. Arch Neurol. 2002;59(5):781\u20136.","journal-title":"Arch Neurol"},{"issue":"9","key":"133_CR11","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","volume":"58","author":"G Farhat","year":"2002","unstructured":"Farhat G, Yamout B, Mikati MA, et al. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology. 2002;58(9):1348\u201353.","journal-title":"Neurology"},{"issue":"3","key":"133_CR12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.57.3.445","volume":"57","author":"Y Sato","year":"2001","unstructured":"Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 2001;57(3):445\u20139.","journal-title":"Neurology"},{"issue":"2","key":"133_CR13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0022-3476(95)70304-7","volume":"127","author":"RD Sheth","year":"1995","unstructured":"Sheth RD, Wesolowski CA, Jacob JC, et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr. 1995;127(2):256\u201362.","journal-title":"J Pediatr"},{"issue":"1","key":"133_CR14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1528-1167.2007.01253.x","volume":"49","author":"RD Sheth","year":"2008","unstructured":"Sheth RD, Binkley N, Hermann BP. Gender differences in bone mineral density in epilepsy. Epilepsia. 2008;49(1):125\u201331.","journal-title":"Epilepsia"},{"issue":"4","key":"133_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.spen.2007.08.006","volume":"14","author":"EA Samaniego","year":"2007","unstructured":"Samaniego EA, Sheth RD. Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol. 2007;14(4):196\u2013200.","journal-title":"Semin Pediatr Neurol"},{"issue":"9","key":"133_CR16","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1528-1167.2009.02082.x","volume":"50","author":"G Coppola","year":"2009","unstructured":"Coppola G, Fortunato D, Auricchio G, et al. Bone mineral density in children, adolescents, and young adults with epilepsy. Epilepsia. 2009;50(9):2140\u20136.","journal-title":"Epilepsia"},{"issue":"3","key":"133_CR17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1212\/01.wnl.0000284595.45880.93","volume":"70","author":"RD Sheth","year":"2008","unstructured":"Sheth RD, Binkley N, Hermann BP. Progressive bone deficit in epilepsy. Neurology. 2008;70(3):170\u20136.","journal-title":"Neurology"},{"issue":"1 Pt 1","key":"133_CR18","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1542\/peds.110.1.e5","volume":"110","author":"RC Henderson","year":"2002","unstructured":"Henderson RC, Lark RK, Gurka MJ, et al. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics. 2002;110(1 Pt 1):e5.","journal-title":"Pediatrics"},{"issue":"3","key":"133_CR19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.seizure.2010.01.006","volume":"19","author":"B Menon","year":"2010","unstructured":"Menon B, Harinarayan CV. The effect of anti epileptic drug therapy on serum 25-hydroxyvitamin D and parameters of calcium and bone metabolism\u2013a longitudinal study. Seizure. 2010;19(3):153\u20138.","journal-title":"Seizure"},{"issue":"3","key":"133_CR20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1469-8749.2009.03402.x","volume":"52","author":"M Rauchenzauner","year":"2010","unstructured":"Rauchenzauner M, Griesmacher A, Tatarczyk T, et al. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children. Dev Med Child Neurol. 2010;52(3):283\u20138.","journal-title":"Dev Med Child Neurol"},{"issue":"12","key":"133_CR21","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00431-008-0672-7","volume":"167","author":"S Nettekoven","year":"2008","unstructured":"Nettekoven S, Str\u00f6hle A, Trunz B, et al. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr. 2008;167(12):1369\u201377.","journal-title":"Eur J Pediatr"},{"key":"133_CR22","first-page":"174","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"P Szulc","year":"2009","unstructured":"Szulc P, Delmas PD. Biochemical markers of bone turnover in osteoporosis. In: Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. New York: Lippincott Williams & Williams; 2009. p. 174\u20139."},{"issue":"18","key":"133_CR23","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.wnl.0000310981.44676.de","volume":"70","author":"AM Pack","year":"2008","unstructured":"Pack AM, Morrell MJ, Randall A, McMahon DJ, Shane E. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology. 2008;70(18):1586\u201393.","journal-title":"Neurology"},{"issue":"7","key":"133_CR24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1359\/jbmr.1998.13.7.1134","volume":"13","author":"M Sowers","year":"1998","unstructured":"Sowers M, Crutchfield M, Bandekar R, et al. Bone mineral density and its change in pre- and perimenopausal white women: the Michigan Bone Health Study. J Miner Res. 1998;13(7):1134\u201340.","journal-title":"J Miner Res"},{"issue":"11","key":"133_CR25","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1212\/01.WNL.0000125185.74276.D2","volume":"62","author":"KE Ensrud","year":"2004","unstructured":"Ensrud KE, Walczak TS, Blackwell T, Ensrud ER, Bowman PJ, Stone KL. Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology. 2004;62(11):2051\u20137.","journal-title":"Neurology"},{"issue":"3","key":"133_CR26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1531-8249(200003)47:3<385::AID-ANA18>3.0.CO;2-W","volume":"47","author":"A Verrotti","year":"2000","unstructured":"Verrotti A, Greco R, Morgese G, Chiarelli F. Increased bone turnover in epileptic patients treated with carbamazepine. Ann Neurol. 2000;47(3):385\u20138.","journal-title":"Ann Neurol"},{"issue":"12","key":"133_CR27","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1528-1157.2002.13002.x","volume":"43","author":"A Verrotti","year":"2002","unstructured":"Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia. 2002;43(12):1488\u201392.","journal-title":"Epilepsia"},{"issue":"2","key":"133_CR28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2006.11.007","volume":"10","author":"SH Kim","year":"2007","unstructured":"Kim SH, Lee JW, Choi KG, Chung HW, Lee HW. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy and Behavior. 2007;10(2):291\u20135.","journal-title":"Epilepsy and Behavior"},{"issue":"3","key":"133_CR29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1528-1167.2006.00460.x","volume":"47","author":"S Mintzer","year":"2006","unstructured":"Mintzer S, Boppana P, Toguri J, et al. Vitamin D levels and bone turnover in epilepsy taking carbamazepine or oxcarbazepine. Epilepsia. 2006;47(3):510\u20135.","journal-title":"Epilepsia"},{"issue":"4","key":"133_CR30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pediatrneurol.2008.07.001","volume":"39","author":"A Cansu","year":"2008","unstructured":"Cansu A, Yesilkaya E, Serdaro\u011flu A, et al. Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatr Neurol. 2008;39(4):266\u201371.","journal-title":"Pediatr Neurol"},{"issue":"9","key":"133_CR31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1528-1157.2001.416800.x","volume":"42","author":"CY Gou","year":"2001","unstructured":"Gou CY, Ronen GM, Atkinson SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia. 2001;42(9):1141\u20137.","journal-title":"Epilepsia"},{"issue":"2","key":"133_CR32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1468-1331.2009.02773.x","volume":"17","author":"A Verrotti","year":"2010","unstructured":"Verrotti A, Agostinelli S, Coppola G, Parisi P, Chiarelli F. A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy. Eur J Neurol. 2010;17(2):232\u20137.","journal-title":"Eur J Neurol"},{"issue":"10","key":"133_CR33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1212\/01.wnl.0000324919.86696.a9","volume":"71","author":"KE Ensrud","year":"2008","unstructured":"Ensrud KE, Walczak TS, Blackwell TL, et al. Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology 2008, 71(10):723\u201330.","journal-title":"Neurology"},{"issue":"4","key":"133_CR34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pediatrneurol.2007.05.018","volume":"37","author":"RD Sheth","year":"2007","unstructured":"Sheth RD, Hermann BP. Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol. 2007;37(4):250\u20134.","journal-title":"Pediatr Neurol"},{"issue":"4","key":"133_CR35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbmr.5650060406","volume":"6","author":"WM Pierce Jr","year":"1991","unstructured":"Pierce Jr WM, Nardin GF, Fuqua MF, et al. Effect of chronic carbonic anhydrase inhibitor therapy on bone and mineral density in white women. J Bone Miner Res. 1991;6(4):347\u201354.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"133_CR36","first-page":"1","volume":"48","author":"LS Nissen-Meyer","year":"2007","unstructured":"Nissen-Meyer LS, Svalheim S, Tauboll E, et al. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism. Epilepsia. 2007;48(10):1\u201311.","journal-title":"Epilepsia"},{"issue":"1","key":"133_CR37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI21867","volume":"115","author":"JM Pascussi","year":"2005","unstructured":"Pascussi JM, Robert A, Nguyen M, et al. Possible involvement of pregnane X receptor-enhanced CYP 24 expression in drug-induced osteomalacia. J Clin Invest. 2005;115(1):177\u201386.","journal-title":"J Clin Invest"},{"issue":"6","key":"133_CR38","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI27793","volume":"116","author":"C Zhou","year":"2006","unstructured":"Zhou C, Assem M, Tay JC, et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest. 2006;116(6):1703\u201312.","journal-title":"J Clin Invest"},{"issue":"2","key":"133_CR39","first-page":"781","volume":"57","author":"AM Pack","year":"2005","unstructured":"Pack AM, Morrell MJ, Marcus R, et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol. 2005;57(2):781\u20136.","journal-title":"Ann Neurol"},{"issue":"6","key":"133_CR40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/seiz.1999.0301","volume":"8","author":"LJ Stephen","year":"1999","unstructured":"Stephen LJ, McLellan AR, Harrison JH, et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure. 1999;8(6):339\u201342.","journal-title":"Seizure"},{"issue":"1","key":"133_CR41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2005.06.018","volume":"21","author":"R Bhatt","year":"2006","unstructured":"Bhatt R, Bhatt S, Hameed M, Rameshwar P, Siegel A. Amygdaloid kindled seizures can induce functional and pathological changes in thymus of rat: role of the sympathetic nervous system. Neurobiol Dis. 2006;21(1):127\u201337.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"133_CR42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1468-1331.2010.03103.x","volume":"18","author":"I Lambrinoudaki","year":"2011","unstructured":"Lambrinoudaki I, Kaparos G, Armeni E, et al. BsmI vitamin D receptor\u2019s polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy. Eur J Neurol 2011;18(1):93\u20138.","journal-title":"Eur J Neurol"},{"issue":"1","key":"133_CR43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-1331.2010.03137.x","volume":"18","author":"AM Pack","year":"2011","unstructured":"Pack AM. Genetic variation may clarify the relationship between epilepsy, antiepileptic drugs, and bone health. Eur J Neurol. 2011;18(1):3\u20134.","journal-title":"Eur J Neurol."},{"key":"133_CR44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1359\/JBMR.0301265","volume":"19","author":"A Thakkinstian","year":"2004","unstructured":"Thakkinstian A, D\u2019Este C, Eisman J, Nguyen T, Attia J. Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res. 2004;19:419\u201328.","journal-title":"J Bone Miner Res."},{"key":"133_CR45","unstructured":"FRAX\u00ae: WHO risk factor tool. Available at: http:\/\/www.sheffield.ac.uk\/FRAX\/ . Accessed April 8, 2011."},{"issue":"11","key":"133_CR46","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1212\/01.wnl.0000247107.54562.0e","volume":"67","author":"MA Mikati","year":"2006","unstructured":"Mikati MA, Dib L, Yamout B, et al. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology. 2006;67(11):2005\u201314.","journal-title":"Neurology"},{"key":"133_CR47","unstructured":"IOM (Institute of Medicine). 2011. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press. Available at: http:\/\/www.iom.edu\/vitamind . Accessed April 8, 2011."}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0133-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-011-0133-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0133-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T16:43:06Z","timestamp":1712421786000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-011-0133-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,11]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["133"],"URL":"https:\/\/doi.org\/10.1007\/s11940-011-0133-x","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,11]]}}}